News Releases Year None2026202520242023202220212020201920182017 NuCana Reports Third Quarter 2021 Financial Results and Provides Business Update Nov 18, 2021 NuCana to Present at the Jefferies 2021 London Healthcare Conference Nov 10, 2021 NuCana Appoints Elliott M. Levy, M.D. to its Board of Directors Nov 01, 2021 NuCana Receives Fast Track Designation from the U.S. Food and Drug Administration for Acelarin® (NUC-1031) for the Treatment of Biliary Tract Cancer Sep 29, 2021 NuCana Announces Four Poster Presentations at the ESMO Congress 2021 Sep 16, 2021 NuCana Announces Enrollment of Required Number of Patients to Conduct First Interim Analysis in the Phase III Biliary Tract Cancer Study Sep 15, 2021 NuCana to Participate in Three Upcoming Investor Conferences Sep 01, 2021 NuCana Reports Second Quarter 2021 Financial Results and Provides Business Update Aug 19, 2021 NuCana Appoints Jeffrey D. Bloss, M.D. as Chief Medical Officer Aug 10, 2021 NuCana to Present at the Jefferies Virtual Healthcare Conference May 25, 2021 Pagination First page « first Previous page ‹ previous … Page 4 Page 5 Page 6 Page 7 Current page 8 Page 9 Page 10 Page 11 Page 12 … Next page next › Last page last »
NuCana Receives Fast Track Designation from the U.S. Food and Drug Administration for Acelarin® (NUC-1031) for the Treatment of Biliary Tract Cancer Sep 29, 2021
NuCana Announces Enrollment of Required Number of Patients to Conduct First Interim Analysis in the Phase III Biliary Tract Cancer Study Sep 15, 2021